IBDEI1IG ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,24159,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24159,1,3,0)
 ;;=3^Seborrheic Dermatitis NEC
 ;;^UTILITY(U,$J,358.3,24159,1,4,0)
 ;;=4^L21.8
 ;;^UTILITY(U,$J,358.3,24159,2)
 ;;=^303310
 ;;^UTILITY(U,$J,358.3,24160,0)
 ;;=L21.9^^107^1201^303
 ;;^UTILITY(U,$J,358.3,24160,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24160,1,3,0)
 ;;=3^Seborrheic Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,24160,1,4,0)
 ;;=4^L21.9
 ;;^UTILITY(U,$J,358.3,24160,2)
 ;;=^188703
 ;;^UTILITY(U,$J,358.3,24161,0)
 ;;=L23.7^^107^1201^31
 ;;^UTILITY(U,$J,358.3,24161,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24161,1,3,0)
 ;;=3^Allergic Contact Dermatitis d/t Plants
 ;;^UTILITY(U,$J,358.3,24161,1,4,0)
 ;;=4^L23.7
 ;;^UTILITY(U,$J,358.3,24161,2)
 ;;=^5009122
 ;;^UTILITY(U,$J,358.3,24162,0)
 ;;=L23.9^^107^1201^32
 ;;^UTILITY(U,$J,358.3,24162,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24162,1,3,0)
 ;;=3^Allergic Contact Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,24162,1,4,0)
 ;;=4^L23.9
 ;;^UTILITY(U,$J,358.3,24162,2)
 ;;=^5009125
 ;;^UTILITY(U,$J,358.3,24163,0)
 ;;=L24.9^^107^1201^166
 ;;^UTILITY(U,$J,358.3,24163,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24163,1,3,0)
 ;;=3^Irritant Contact Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,24163,1,4,0)
 ;;=4^L24.9
 ;;^UTILITY(U,$J,358.3,24163,2)
 ;;=^5009136
 ;;^UTILITY(U,$J,358.3,24164,0)
 ;;=L25.9^^107^1201^117
 ;;^UTILITY(U,$J,358.3,24164,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24164,1,3,0)
 ;;=3^Contact Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,24164,1,4,0)
 ;;=4^L25.9
 ;;^UTILITY(U,$J,358.3,24164,2)
 ;;=^5133647
 ;;^UTILITY(U,$J,358.3,24165,0)
 ;;=L26.^^107^1201^151
 ;;^UTILITY(U,$J,358.3,24165,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24165,1,3,0)
 ;;=3^Exfoliative Dermatitis
 ;;^UTILITY(U,$J,358.3,24165,1,4,0)
 ;;=4^L26.
 ;;^UTILITY(U,$J,358.3,24165,2)
 ;;=^263886
 ;;^UTILITY(U,$J,358.3,24166,0)
 ;;=L27.0^^107^1201^305
 ;;^UTILITY(U,$J,358.3,24166,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24166,1,3,0)
 ;;=3^Skin Eruption d/t Drugs/Meds,Generalized
 ;;^UTILITY(U,$J,358.3,24166,1,4,0)
 ;;=4^L27.0
 ;;^UTILITY(U,$J,358.3,24166,2)
 ;;=^5009144
 ;;^UTILITY(U,$J,358.3,24167,0)
 ;;=L27.1^^107^1201^306
 ;;^UTILITY(U,$J,358.3,24167,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24167,1,3,0)
 ;;=3^Skin Eruption d/t Drugs/Meds,Localized
 ;;^UTILITY(U,$J,358.3,24167,1,4,0)
 ;;=4^L27.1
 ;;^UTILITY(U,$J,358.3,24167,2)
 ;;=^5009145
 ;;^UTILITY(U,$J,358.3,24168,0)
 ;;=L29.0^^107^1201^290
 ;;^UTILITY(U,$J,358.3,24168,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24168,1,3,0)
 ;;=3^Pruritus Ani
 ;;^UTILITY(U,$J,358.3,24168,1,4,0)
 ;;=4^L29.0
 ;;^UTILITY(U,$J,358.3,24168,2)
 ;;=^100061
 ;;^UTILITY(U,$J,358.3,24169,0)
 ;;=L29.9^^107^1201^291
 ;;^UTILITY(U,$J,358.3,24169,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24169,1,3,0)
 ;;=3^Pruritus,Unspec
 ;;^UTILITY(U,$J,358.3,24169,1,4,0)
 ;;=4^L29.9
 ;;^UTILITY(U,$J,358.3,24169,2)
 ;;=^5009153
 ;;^UTILITY(U,$J,358.3,24170,0)
 ;;=L30.0^^107^1201^270
 ;;^UTILITY(U,$J,358.3,24170,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24170,1,3,0)
 ;;=3^Nummular Dermatitis
 ;;^UTILITY(U,$J,358.3,24170,1,4,0)
 ;;=4^L30.0
 ;;^UTILITY(U,$J,358.3,24170,2)
 ;;=^186823
 ;;^UTILITY(U,$J,358.3,24171,0)
 ;;=L30.1^^107^1201^143
 ;;^UTILITY(U,$J,358.3,24171,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24171,1,3,0)
 ;;=3^Dyshidrosis
 ;;^UTILITY(U,$J,358.3,24171,1,4,0)
 ;;=4^L30.1
